Wells Fargo’s Predictive Oncology POAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $830 | Hold |
1,000
| – | – | ﹤0.01% | 5866 |
|
|
2025
Q1 | $1.52K | Hold |
1,000
| – | – | ﹤0.01% | 5721 |
|
|
2024
Q4 | $820 | Hold |
1,000
| – | – | ﹤0.01% | 5773 |
|
|
2024
Q3 | $788 | Hold |
1,000
| – | – | ﹤0.01% | 5731 |
|
|
2024
Q2 | $1.04K | Buy |
1,000
+968
| +3,025% | +$1.01K | ﹤0.01% | 5702 |
|
|
2024
Q1 | $82 | Buy |
32
+1
| +3% | +$3 | ﹤0.01% | 6314 |
|
|
2023
Q4 | $102 | Sell |
31
-298
| -91% | -$981 | ﹤0.01% | 6321 |
|
|
2023
Q3 | $1.05K | Buy |
329
+25
| +8% | +$80 | ﹤0.01% | 5813 |
|
|
2023
Q2 | $1.48K | Buy |
304
+2
| +0.7% | +$10 | ﹤0.01% | 5951 |
|
|
2023
Q1 | $1.98K | Hold |
302
| – | – | ﹤0.01% | 5902 |
|
|
2022
Q4 | $1.85K | Buy |
302
+1
| +0.3% | +$6 | ﹤0.01% | 5699 |
|
|
2022
Q3 | $2K | Buy |
301
+179
| +147% | +$1.19K | ﹤0.01% | 5846 |
|
|
2022
Q2 | $1K | Buy |
122
+2
| +2% | +$16 | ﹤0.01% | 6277 |
|
|
2022
Q1 | $2K | Hold |
120
| – | – | ﹤0.01% | 6332 |
|
|
2021
Q4 | $2K | Hold |
120
| – | – | ﹤0.01% | 6343 |
|
|
2021
Q3 | $4K | Buy |
120
+5
| +4% | +$167 | ﹤0.01% | 6117 |
|
|
2021
Q2 | $3K | Buy |
115
+4
| +4% | +$104 | ﹤0.01% | 6136 |
|
|
2021
Q1 | $2K | Buy |
111
+106
| +2,120% | +$1.91K | ﹤0.01% | 6272 |
|
|
2020
Q4 | $0 | Buy |
5
+1
| +25% | – | ﹤0.01% | 6493 |
|
|
2020
Q3 | $0 | Buy |
4
+3
| +300% | – | ﹤0.01% | 6333 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6253 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6223 |
|